- Browse by Author
Browsing by Author "Chekani, Farid"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Development and Temporal Validation of an Electronic Medical Record-Based Insomnia Prediction Model Using Data from a Statewide Health Information Exchange(MDPI, 2023-05-05) Holler, Emma; Chekani, Farid; Ai, Jizhou; Meng, Weilin; Khandker, Rezaul Karim; Ben Miled, Zina; Owora, Arthur; Dexter, Paul; Campbell, Noll; Solid, Craig; Boustani, Malaz; Electrical and Computer Engineering, School of Engineering and TechnologyThis study aimed to develop and temporally validate an electronic medical record (EMR)-based insomnia prediction model. In this nested case-control study, we analyzed EMR data from 2011–2018 obtained from a statewide health information exchange. The study sample included 19,843 insomnia cases and 19,843 controls matched by age, sex, and race. Models using different ML techniques were trained to predict insomnia using demographics, diagnosis, and medication order data from two surveillance periods: −1 to −365 days and −180 to −365 days before the first documentation of insomnia. Separate models were also trained with patient data from three time periods (2011–2013, 2011–2015, and 2011–2017). After selecting the best model, predictive performance was evaluated on holdout patients as well as patients from subsequent years to assess the temporal validity of the models. An extreme gradient boosting (XGBoost) model outperformed all other classifiers. XGboost models trained on 2011–2017 data from −1 to −365 and −180 to −365 days before index had AUCs of 0.80 (SD 0.005) and 0.70 (SD 0.006), respectively, on the holdout set. On patients with data from subsequent years, a drop of at most 4% in AUC is observed for all models, even when there is a five-year difference between the collection period of the training and the temporal validation data. The proposed EMR-based prediction models can be used to identify insomnia up to six months before clinical detection. These models may provide an inexpensive, scalable, and longitudinally viable method to screen for individuals at high risk of insomnia.Item Modeling acute care utilization: practical implications for insomnia patients(Springer Nature, 2023-02-07) Chekani, Farid; Zhu, Zitong; Khandker, Rezaul Karim; Ai, Jizhou; Meng, Weilin; Holler, Emma; Dexter, Paul; Boustani, Malaz; Ben Miled, Zina; Medicine, School of MedicineMachine learning models can help improve health care services. However, they need to be practical to gain wide-adoption. In this study, we investigate the practical utility of different data modalities and cohort segmentation strategies when designing models for emergency department (ED) and inpatient hospital (IH) visits. The data modalities include socio-demographics, diagnosis and medications. Segmentation compares a cohort of insomnia patients to a cohort of general non-insomnia patients under varying age and disease severity criteria. Transfer testing between the two cohorts is introduced to demonstrate that an insomnia-specific model is not necessary when predicting future ED visits, but may have merit when predicting IH visits especially for patients with an insomnia diagnosis. The results also indicate that using both diagnosis and medications as a source of data does not generally improve model performance and may increase its overhead. Based on these findings, the proposed evaluation methodologies are recommended to ascertain the utility of disease-specific models in addition to the traditional intra-cohort testing.Item The impact of antipsychotic adherence on acute care utilization(BMC, 2023-01-24) Perkins, Anthony J.; Khandker, Rezaul; Overley, Ashley; Solid, Craig A.; Chekani, Farid; Roberts, Anna; Dexter, Paul; Boustani, Malaz A.; Hulvershorn, Leslie; Medicine, School of MedicineBackground: Non-adherence to psychotropic medications is common in schizophrenia and bipolar disorders (BDs) leading to adverse outcomes. We examined patterns of antipsychotic use in schizophrenia and BD and their impact on subsequent acute care utilization. Methods: We used electronic health record (EHR) data of 577 individuals with schizophrenia, 795 with BD, and 618 using antipsychotics without a diagnosis of either illness at two large health systems. We structured three antipsychotics exposure variables: the proportion of days covered (PDC) to measure adherence; medication switch as a new antipsychotic prescription that was different than the initial antipsychotic; and medication stoppage as the lack of an antipsychotic order or fill data in the EHR after the date when the previous supply would have been depleted. Outcome measures included the frequency of inpatient and emergency department (ED) visits up to 12 months after treatment initiation. Results: Approximately half of the study population were adherent to their antipsychotic medication (a PDC ≥ 0.80): 53.6% of those with schizophrenia, 52.4% of those with BD, and 50.3% of those without either diagnosis. Among schizophrenia patients, 22.5% switched medications and 15.1% stopped therapy. Switching and stopping occurred in 15.8% and 15.1% of BD patients and 7.4% and 20.1% of those without either diagnosis, respectively. Across the three cohorts, non-adherence, switching, and stopping therapy were all associated with increased acute care utilization, even after adjusting for baseline demographics, health insurance, past acute care utilization, and comorbidity. Conclusion: Non-continuous antipsychotic use is common and associated with high acute care utilization.